David Katz - Matrix Asset Advisors
Holding/activity history for Eyepoint Pharmaceuticals Inc (EYPT)
← All EYPT superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $3.50–6.79 · VW $5.18i | SEC | |
| 2020 Q3 | 3,950 | <0.01 | $5.10 | $20,000 | SEC | ||
| 2020 Q2 | 3,950 | 0.01 | Add 49.06% | <0.01 | $7.00–12.00 · VW $8.90i | $30,000 | SEC |
| 2020 Q1 | 2,650 | 0.01 | $10.20 | $27,000 | SEC | ||
| 2019 Q4 | 2,650 | 0.01 | $15.50 | $41,000 | SEC | ||
| 2019 Q3 | 2,650 | 0.01 | $18.10 | $48,000 | SEC | ||
| 2019 Q2 | 2,650 | 0.01 | $16.20 | $43,000 | SEC | ||
| 2019 Q1 | 2,650 | 0.01 | Reduce 7.02% | <0.01 | $17.40–28.20 · VW $22.12i | $47,000 | SEC |
| 2018 Q4 | 2,850 | 0.01 | $18.90 | $54,000 | SEC | ||
| 2018 Q3 | 2,850 | 0.02 | $35.80 | $102,000 | SEC | ||
| 2018 Q2 | 2,850 | 0.01 | Buy | 0.01 | $10.70–28.80 · VW $21.63i | $59,000 | SEC |